Tag: Lantus

Is Lantus Insulin Linked to Increased Risk of Cancer? New Study Begins

Recently published studies suggested that insulin glargine (a synthetic insulin preparation marketed under the trade name Lantus), may be associated with a higher risk of certain cancers than other insulins or oral glucose lowering medications. However, these studies were unable to control for important factors such as obesity that may have driven the association...
0 Shares